The University of Chicago Header Logo

Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review.

Comparison of the FDA and EMA guidance on drug development in ulcerative colitis: an expert panel review. J Crohns Colitis. 2025 Jul 03; 19(7).

View in: PubMed